Virtual Reality for Pain in Acute Orthopedic Injuries
Primary Purpose
Injuries, Injury Arm, Injury;Sports
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
RelieveVRx
Sponsored by
About this trial
This is an interventional treatment trial for Injuries focused on measuring pain, disability, injury, orthopedics, rehabilitation, mind-body
Eligibility Criteria
Inclusion Criteria:
- Outpatient adults in the Level 1 Trauma Center
- Age 18 or older
- Able to meaningfully participate meaningfully (English fluency and literacy) and stable living situation
- Acute musculoskeletal injury (e.g., fracture, dislocation, rupture) 1-2 months earlier (acute phase).
- Pain Catastrophizing Scale ≥20 or Pain Anxiety Symptom Scale-20 ≥40
- Has access to internet (Wi-Fi or wireless)
- Willing to participate and comply with the requirements of the study protocol, including virtual reality program and questionnaire completion No psychotropics or stable for >6 weeks
- Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic medication for a minimum of 6 weeks and willing to maintain a stable dose (i.e., no psychotropics or stable for >6 weeks)
- Cleared by orthopedic surgeon for study participation
Exclusion Criteria:
- Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological diseases that are contraindicated for VR
- Medical condition predisposing to nausea or dizziness.
- Hypersensitivity to flashing light or motion.
- Vision or severe hearing impairment.
- Injury to eyes, face, or neck that impedes comfortable use of virtual reality
- Diagnosed with a medical illness expected to worsen in the next 3 months (e.g., malignancy)
- Other serious injuries that occurred with the orthopedic injury or surgical complications (e.g., infection, need for repeat surgery)
- Current or prior untreated mental illness, substance use disorder, or suicidal ideation
- Self-reported pregnancy
- Currently in litigation or under Workman's Comp
- Practice of cognitive-behavioral therapy, yoga/meditation, or other mind body techniques once per week for 45 minutes or more within the last 3 months
Sites / Locations
- Massachusetts General Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Skills-Based VR
Arm Description
Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.
Outcomes
Primary Outcome Measures
Credibility and Expectancy Questionnaire
Participants' treatment expectancy and perceived credibility, determined by the percentage of participants with scores (range = 3-27) over the scale's midpoint (≥70% good, ≥ 80% excellent).
Client Satisfaction Questionnaire
Participants' treatment satisfaction, determined by the percentage of participants with scores (range = 3-12) over the scale's midpoint (≥70% good, ≥ 80% excellent).
System Usability Scale
Assess global user experience of the VR device, with higher percentile rankings (range = 0-100) indicating greater usability.
Secondary Outcome Measures
Patient's Global Impression of Change
Assess perceptions of overall improvement in pain and physical function during the program.
Motion Sickness and Nausea
Assess adverse experiences with VR, determined by the percentage of participants with responses (range = 0 never to 3 always) below the scale's midpoint (≥70% good, ≥ 80% excellent).
Feasibility of Recruitment
We will report number of participants who agree to participate out of those approached, evaluated at the end of study for all participants (≥70% good, ≥ 80% excellent).
Acceptability of Treatment
Acceptability of virtual reality based on module completion (≥70% complete 6 out of 8 weeks, good; ≥ 80% complete 6 out of 8 weeks, excellent).
Adherence to Pain Surveys
Adherence to smartphone-based surveys of pain intensity (at rest, with activity) and pain interference with daily activities in the last 24 hours (≥70% good, ≥80% excellent).
Feasibility of Outcome Assessments
Feasibility of collecting complete outcome assessments (≥70% have no missing data, good; ≥80% have no missing data, excellent).
Full Information
NCT ID
NCT05552430
First Posted
September 20, 2022
Last Updated
October 17, 2023
Sponsor
Massachusetts General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05552430
Brief Title
Virtual Reality for Pain in Acute Orthopedic Injuries
Official Title
Physical and Psychological Measures of Pain in Acute Orthopedic Injuries: Use of At-home Virtual Reality
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
October 17, 2022 (Actual)
Primary Completion Date
October 12, 2023 (Actual)
Study Completion Date
October 12, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this study is to pilot test a skills-based virtual reality (VR) for acute orthopedic injury. It will measure the feasibility, signals of improvement, exploratory pain mechanisms, and user experience of an established skills-based program (RelieveVRx) for acute orthopedic injury.
Detailed Description
This study will use mixed-methods to investigate the feasibility of skills-based virtual reality (VR) for acute orthopedic injury in an open pilot with individual exit interviews (target N=10). Participants will be patients with acute orthopedic musculoskeletal injuries who are at risk for chronic pain and disability (PCS ≥ 20 and PASS-20 ≥ 40) and meet inclusionary/exclusionary criteria. Participants will be recruited through the MGH Orthopedics Department, flyers, and the Rally research platform. Participants will self-administer a skills-based virtual reality (VR) program at home over an 8-week period. Participants will attend two in-person study assessments to complete study assessments (surveys and an fNIRS imaging session). The primary outcome for the pilot will be a-priori Go/No-Go feasibility markers (feasibility, acceptability, fidelity, credibility, expectancy, satisfaction) of the VR program and data collection procedures to increase the success of subsequent trials. Exploratory measures include: multi-modal assessment of pain intensity, pain-specific coping (catastrophizing, self-efficacy, acceptance), disability, physical function, and emotional function (depression, anxiety, stress). The VR headset will collect usage data and daily smartphone surveys will track changes in pain during the 8-week intervention. Completers will have the opportunity to attend 30 min individual exit interviews to understand patients' perception of the VR and their experience with the study procedures to increase the success of larger trials.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Injuries, Injury Arm, Injury;Sports, Injury, Knee, Injury Wrist, Injury, Ankle, Injury Foot, Injury, Hand, Injury Finger, Injury Leg
Keywords
pain, disability, injury, orthopedics, rehabilitation, mind-body
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Skills-Based VR
Arm Type
Experimental
Arm Description
Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.
Intervention Type
Device
Intervention Name(s)
RelieveVRx
Intervention Description
Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.
Primary Outcome Measure Information:
Title
Credibility and Expectancy Questionnaire
Description
Participants' treatment expectancy and perceived credibility, determined by the percentage of participants with scores (range = 3-27) over the scale's midpoint (≥70% good, ≥ 80% excellent).
Time Frame
Pre-intervention (week 0) only
Title
Client Satisfaction Questionnaire
Description
Participants' treatment satisfaction, determined by the percentage of participants with scores (range = 3-12) over the scale's midpoint (≥70% good, ≥ 80% excellent).
Time Frame
Post-intervention (week 8) only
Title
System Usability Scale
Description
Assess global user experience of the VR device, with higher percentile rankings (range = 0-100) indicating greater usability.
Time Frame
Post-intervention (week 8) only
Secondary Outcome Measure Information:
Title
Patient's Global Impression of Change
Description
Assess perceptions of overall improvement in pain and physical function during the program.
Time Frame
Post-intervention (week 8) only
Title
Motion Sickness and Nausea
Description
Assess adverse experiences with VR, determined by the percentage of participants with responses (range = 0 never to 3 always) below the scale's midpoint (≥70% good, ≥ 80% excellent).
Time Frame
Post-intervention (week 8) only
Title
Feasibility of Recruitment
Description
We will report number of participants who agree to participate out of those approached, evaluated at the end of study for all participants (≥70% good, ≥ 80% excellent).
Time Frame
Throughout the study completion, approximately 1 year
Title
Acceptability of Treatment
Description
Acceptability of virtual reality based on module completion (≥70% complete 6 out of 8 weeks, good; ≥ 80% complete 6 out of 8 weeks, excellent).
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Adherence to Pain Surveys
Description
Adherence to smartphone-based surveys of pain intensity (at rest, with activity) and pain interference with daily activities in the last 24 hours (≥70% good, ≥80% excellent).
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Feasibility of Outcome Assessments
Description
Feasibility of collecting complete outcome assessments (≥70% have no missing data, good; ≥80% have no missing data, excellent).
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Other Pre-specified Outcome Measures:
Title
Pain medications
Description
Number of days that narcotic and non-narcotic pain medications were taken in the last week.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function
Description
Assess one's ability to carry out activities that require physical actions, ranging from self-care to social and work.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Short Musculoskeletal Functional Assessment (SMFA) Questionnaire
Description
Assess disability specific to musculoskeletal injury and pain.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Numerical Rating Scale (NRS)
Description
Assess pain intensity at rest and with activity.
Time Frame
Pre-intervention (week 0), Bi-weekly, Post-intervention (week 8)
Title
Pain Catastrophizing Scale (PCS)
Description
Assess catastrophic thinking about pain.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Pain Anxiety Scale (PASS)
Description
Assess pain-specific anxiety.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Pain Self-Efficacy Questionnaire (PSEQ)
Description
Assess confidence to engage in physical activity despite pain.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Chronic Pain Acceptance Questionnaire (CPAQ)
Description
Assess ability to engage in meaningful activities despite pain.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Center for Epidemiologic Study of Depression (CESD) Scale
Description
Assess depression.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Cognitive and Affective Mindfulness Scale (CAMS)
Description
Assess state of mindfulness taught during the program.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
Title
Defense and Veterans Pain Rating Scale (DVPRS)
Description
Assess pain interference and pain intensity
Time Frame
Pre-intervention (week 0), Bi-weekly, Post-intervention (week 8)
Title
Measure of Current Status (MOCS)
Description
Assess general coping ability taught during the program.
Time Frame
Pre-intervention (week 0), Post-intervention (week 8)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Outpatient adults in the Level 1 Trauma Center
Age 18 or older
Able to meaningfully participate meaningfully (English fluency and literacy) and stable living situation
Acute musculoskeletal injury (e.g., fracture, dislocation, rupture) 1-2 months earlier (acute phase).
Pain Catastrophizing Scale ≥20 or Pain Anxiety Symptom Scale-20 ≥40
Has access to internet (Wi-Fi or wireless)
Willing to participate and comply with the requirements of the study protocol, including virtual reality program and questionnaire completion No psychotropics or stable for >6 weeks
Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic medication for a minimum of 6 weeks and willing to maintain a stable dose (i.e., no psychotropics or stable for >6 weeks)
Cleared by orthopedic surgeon for study participation
Exclusion Criteria:
Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological diseases that are contraindicated for VR
Medical condition predisposing to nausea or dizziness.
Hypersensitivity to flashing light or motion.
Vision or severe hearing impairment.
Injury to eyes, face, or neck that impedes comfortable use of virtual reality
Diagnosed with a medical illness expected to worsen in the next 3 months (e.g., malignancy)
Other serious injuries that occurred with the orthopedic injury or surgical complications (e.g., infection, need for repeat surgery)
Current or prior untreated mental illness, substance use disorder, or suicidal ideation
Self-reported pregnancy
Currently in litigation or under Workman's Comp
Practice of cognitive-behavioral therapy, yoga/meditation, or other mind body techniques once per week for 45 minutes or more within the last 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ryan A Mace, PhD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Virtual Reality for Pain in Acute Orthopedic Injuries
We'll reach out to this number within 24 hrs